Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/101706
| Title: | Clinical evaluation of fiducial marker pre-planning for virtual bronchoscopic navigation implantation in lung tumour patients treated with cyberknife | Authors: | Ku, KM Lam, B Wu, VWC Chan, KT Chan, CYY Cheng, HC Yuen, KMY Cai, J |
Issue Date: | Jun-2022 | Source: | Frontiers in Oncology, June 2022, v. 12, 860641 | Abstract: | Purpose: For the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and Materials: This study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. Results: A total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). Conclusion: Pre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6. |
Keywords: | CyberKnife Dose area product Fiducial marker Lung cancer Virtual bronchoscopic navigation |
Publisher: | Frontiers Research Foundation | Journal: | Frontiers in oncology | EISSN: | 2234-943X | DOI: | 10.3389/fonc.2022.860641 | Rights: | Copyright © 2022 Ku, Lam,Wu, Chan, Chan, Cheng, Yuen and Cai. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. The following publication Ku, K. M., Lam, B., Wu, V. W., Chan, K. T., Chan, C. Y., Cheng, H. C., ... & Cai, J. (2022). Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife. Frontiers in Oncology, 12, 860641 is available at https://doi.org/10.3389/fonc.2022.860641. |
| Appears in Collections: | Journal/Magazine Article |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| fonc-12-860641.pdf | 1.24 MB | Adobe PDF | View/Open |
Page views
88
Citations as of Apr 14, 2025
Downloads
33
Citations as of Apr 14, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.



